Anthony Allen is a finance professional with extensive experience in the healthcare sector. Currently serving as a Finance Project Manager at CEPI since January 2023, Anthony previously held positions including Interim Finance Business Partner at Royal National Orthopaedic Hospital NHS Trust and Finance roles at AMICULUM, where a strong interest in finance training was developed. Earlier roles included Financial Planning Manager and Finance Business Partner at Oxford University Hospitals NHS Foundation Trust, focusing on budgeting, forecasting, and management accounting. Anthony began the career as an Audit Junior at Critchleys. Academic qualifications include a Bachelor of Science in Mathematics and Statistics from Lancaster University, a Professional Accreditation in Accounting and Finance from ACCA, and a degree in Professional Accountancy from the University of London.
This person is not in any offices
CEPI (Coalition for Epidemic Preparedness Innovations)
2 followers
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the COVID-19 pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI’s partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX. CEPI’s 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Betacoronaviruses, and create a “library” of vaccine candidates for use against known and unknown pathogens. The plan is available at www.endpandemics.cepi.net